Sensus Healthcare, Inc. (SRTS) Stock Falls Amid Market Uptick: What Investors Need to Know

Group 1 - Sensus Healthcare, Inc. (SRTS) stock closed at $4.22, down 0.47% from the previous day, underperforming compared to the S&P 500's gain of 0.44% [1] - The stock has decreased by 7.22% over the past month, contrasting with the Medical sector's gain of 1.16% and the S&P 500's gain of 10.62% [1] Group 2 - The upcoming earnings report for Sensus Healthcare is scheduled for May 15, 2025, with projected earnings per share (EPS) of $0.04, indicating a 71.43% decrease year-over-year [2] - Revenue is expected to be $7.27 million, reflecting a 31.8% decline compared to the same quarter last year [2] Group 3 - For the annual period, Zacks Consensus Estimates predict earnings of $0.29 per share and revenue of $43.45 million, representing changes of -29.27% and +3.93% respectively from the previous year [3] Group 4 - Recent changes to analyst estimates for Sensus Healthcare reflect shifting short-term business dynamics, with positive revisions indicating a favorable outlook on the company's health and profitability [4] Group 5 - The Zacks Rank system, which incorporates estimate changes, currently ranks Sensus Healthcare at 4 (Sell), with the consensus EPS estimate remaining unchanged over the past month [6] Group 6 - Sensus Healthcare's Forward P/E ratio is 14.88, which is a discount compared to the industry's average Forward P/E of 25.35 [7] - The Medical - Instruments industry, part of the Medical sector, holds a Zacks Industry Rank of 84, placing it in the top 35% of over 250 industries [7]